# OnCo record adicet-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/adicet-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "adicet-bio" ;
  schema:name "Adicet Bio"@en ;
  schema:description "Adicet makes off-the-shelf immune cell therapies from donor gamma delta T cells, a rarer type of T cell. Its lead programme is now aimed at lupus and other autoimmune diseases, with a prostate cancer candidate expected to enter the clinic in late 2026."@en ;
  schema:url <https://onco.cc/companies/adicet-bio/>, <https://www.adicetbio.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.adicetbio.com/>, <https://www.sec.gov/Archives/edgar/data/1720580/000172058026000049/acet-ex99_1.htm>, <https://www.sec.gov/Archives/edgar/data/1720580/000119312526005486/acet-ex99_1.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-cell-therapy/>, <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/in-vivo-car-t/> ;
  onco:drugs <https://onco.cc/drugs/adi-270/> .